Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2885

1.

Circulating soluble LR11, a differentiation regulator for vascular cells, is increased during pregnancy and exaggerated in patients with pre-eclampsia.

Ishida H, Jiang M, Ebinuma H, Hiruta N, Schneider WJ, Kinoshita T, Bujo H.

Clin Chim Acta. 2019 Jul 9. pii: S0009-8981(19)31938-2. doi: 10.1016/j.cca.2019.07.001. [Epub ahead of print]

PMID:
31299181
2.

Abnormal glucose tolerance in a patient with pheochromocytoma and ACTH-independent subclinical Cushing's syndrome involving the same adrenal gland.

Morita N, Hosaka T, Yamazaki Y, Takahashi K, Sasano H, Ishida H.

J Int Med Res. 2019 Jul 1:300060519855179. doi: 10.1177/0300060519855179. [Epub ahead of print] No abstract available.

PMID:
31256733
3.

Gastric candidiasis developed after administration of potassium-competitive acid blocker.

Kato S, Akasaka T, Kawamoto Y, Mori K, Ishida H.

Gastrointest Endosc. 2019 Jun 17. pii: S0016-5107(19)31955-8. doi: 10.1016/j.gie.2019.06.010. [Epub ahead of print] No abstract available.

PMID:
31220443
4.

Correction: Association between ultraviolet radiation exposure dose and cataract in Han people living in China and Taiwan: A cross-sectional study.

Miyashita H, Hatsusaka N, Shibuya E, Mita N, Yamazaki M, Shibata T, Ishida H, Ukai Y, Kubo E, Sasaki H.

PLoS One. 2019 Jun 20;14(6):e0218857. doi: 10.1371/journal.pone.0218857. eCollection 2019.

5.

In Vitro and In Vivo Evaluation of Starfish Bone-Derived β-Tricalcium Phosphate as a Bone Substitute Material.

Ishida H, Haniu H, Takeuchi A, Ueda K, Sano M, Tanaka M, Takizawa T, Sobajima A, Kamanaka T, Saito N.

Materials (Basel). 2019 Jun 11;12(11). pii: E1881. doi: 10.3390/ma12111881.

6.

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum.

Int J Clin Oncol. 2019 Jun 15. doi: 10.1007/s10147-019-01485-z. [Epub ahead of print]

PMID:
31203527
7.

Japan Korea Transplantation Forum 2018.

Tanabe K, Eguchi S, Ishida H.

Transplant Proc. 2019 Jun;51(5):1477. doi: 10.1016/j.transproceed.2019.05.006. No abstract available.

PMID:
31155181
8.

p- tert-Butyl Groups Improve the Utility of Aromatic Protecting Groups in Carbohydrate Synthesis.

Asano S, Tanaka HN, Imamura A, Ishida H, Ando H.

Org Lett. 2019 Jun 7;21(11):4197-4200. doi: 10.1021/acs.orglett.9b01372. Epub 2019 May 30.

PMID:
31145627
9.

Total Synthesis of Sialyl Inositol Phosphosphingolipids CJP-2, CJP-3, and CJP-4 Isolated from Feather Star Comanthus japonica.

Goto K, Tamai H, Takeda Y, Tanaka HN, Mizuno T, Imamura A, Ishida H, Kiso M, Ando H.

Org Lett. 2019 Jun 7;21(11):4054-4057. doi: 10.1021/acs.orglett.9b01229. Epub 2019 May 22.

PMID:
31117701
10.

Influenza D Virus Infection in Dromedary Camels, Ethiopia.

Murakami S, Odagiri T, Melaku SK, Bazartseren B, Ishida H, Takenaka-Uema A, Muraki Y, Sentsui H, Horimoto T.

Emerg Infect Dis. 2019 Jun;25(6):1224-1226. doi: 10.3201/eid2506.181158.

11.

Constrained sialic acid donors enable selective synthesis of α-glycosides.

Komura N, Kato K, Udagawa T, Asano S, Tanaka HN, Imamura A, Ishida H, Kiso M, Ando H.

Science. 2019 May 17;364(6441):677-680. doi: 10.1126/science.aaw4866.

PMID:
31097666
12.

Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER).

Moriwaki T, Sakai Y, Ishida H, Yamamoto Y, Endo S, Kuramochi H, Sato M, Hatachi Y, Bando Y, Maeba T, Ikezawa K, Shimada M, Amagai K, Morimoto M, Kobayashi K, Tsuji A, Nishina T, Hyodo I.

Int J Clin Oncol. 2019 May 14. doi: 10.1007/s10147-019-01465-3. [Epub ahead of print]

PMID:
31089842
13.

Histological analysis of fundic gland polyps secondary to PPI therapy.

Fukuda M, Ishigaki H, Sugimoto M, Mukaisho KI, Matsubara A, Ishida H, Moritani S, Itoh Y, Sugihara H, Andoh A, Ogasawara K, Murakami K, Kushima R.

Histopathology. 2019 May 14. doi: 10.1111/his.13902. [Epub ahead of print]

PMID:
31087669
14.

Current protocols and outcomes of ABO-incompatible kidney transplantation based on a single-center experience.

Okumi M, Kakuta Y, Unagami K, Takagi T, Iizuka J, Inui M, Ishida H, Tanabe K.

Transl Androl Urol. 2019 Apr;8(2):126-133. doi: 10.21037/tau.2019.03.05. Review.

15.

Outcomes, complications, and economic impact of ABO-incompatible living kidney transplantation: A single-center Japanese cohort study.

Kakuta Y, Okumi M, Unagami K, Iizuka J, Takagi T, Ishida H, Tanabe K.

Clin Transplant. 2019 Jun;33(6):e13591. doi: 10.1111/ctr.13591. Epub 2019 Jun 3.

PMID:
31077450
16.

Favorable outcome with direct-acting antiviral treatment in hepatitis C patients coinfected with HIV.

Ishida H, Ishihara A, Tanaka S, Iwasaki T, Hasegawa H, Akasaka T, Sakakibara Y, Nakazuru S, Uehira T, Shirasaka T, Mita E.

Hepatol Res. 2019 May 10. doi: 10.1111/hepr.13360. [Epub ahead of print]

PMID:
31074580
17.

Clinical outcome of osteosarcoma and its correlation with programmed death-ligand 1 and T cell activation markers.

Yoshida K, Okamoto M, Sasaki J, Kuroda C, Ishida H, Ueda K, Okano S, Ideta H, Kamanaka T, Sobajima A, Takizawa T, Kito M, Aoki K, Uemura T, Haniu H, Kato H, Saito N.

Onco Targets Ther. 2019 Apr 3;12:2513-2518. doi: 10.2147/OTT.S198421. eCollection 2019.

18.

A prospective multi-center registry concerning the clinical performance of laparoscopic colorectal surgery using an absorbable adhesion barrier (INTERCEED®) made of oxidized regenerated cellulose.

Watanabe J, Ishida F, Ishida H, Fukunaga Y, Watanabe K, Naito M, Watanabe M.

Surg Today. 2019 Apr 29. doi: 10.1007/s00595-019-01816-7. [Epub ahead of print]

PMID:
31037393
19.

Association between ultraviolet radiation exposure dose and cataract in Han people living in China and Taiwan: A cross-sectional study.

Miyashita H, Hatsusaka N, Shibuya E, Mita N, Yamazaki M, Shibata T, Ishida H, Ukai Y, Kubo E, Sasaki H.

PLoS One. 2019 Apr 25;14(4):e0215338. doi: 10.1371/journal.pone.0215338. eCollection 2019. Erratum in: PLoS One. 2019 Jun 20;14(6):e0218857.

20.

The interaction between post-transplant anemia and allograft function in kidney transplantation: The Japan Academic Consortium of Kidney Transplantation-II study.

Okumi M, Okabe Y, Unagami K, Kakuta Y, Iizuka J, Takagi T, Shirakawa H, Shimizu T, Omoto K, Ishida H, Nakamura M, Tanabe K; Japan Academic Consortium of Kidney Transplantation (JACK).

Clin Exp Nephrol. 2019 Apr 24. doi: 10.1007/s10157-019-01737-2. [Epub ahead of print]

PMID:
31020441
21.

Fetal echocardiographic prediction score for perinatal mortality of tricuspid valve malformation and Ebstein anomaly.

Torigoe F, Ishida H, Ishii Y, Ishii R, Narita J, Kawazu Y, Kayatani F, Inamura N.

Ultrasound Obstet Gynecol. 2019 Apr 22. doi: 10.1002/uog.20302. [Epub ahead of print]

PMID:
31008542
22.

Association between tumor contact surface area and parenchymal volume change in robot-assisted laparoscopic partial nephrectomy carried out using the enucleation technique.

Takagi T, Yoshida K, Kondo T, Kobayashi H, Iizuka J, Okumi M, Ishida H, Tanabe K.

Int J Urol. 2019 Jul;26(7):745-751. doi: 10.1111/iju.14004. Epub 2019 Apr 18.

PMID:
31001853
23.

Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracil.

Sekido M, Fujita KI, Kubota Y, Ishida H, Takahashi T, Ohkuma R, Tsunoda T, Ishikawa F, Shibanuma M, Sasaki Y.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1127-1135. doi: 10.1007/s00280-019-03837-y. Epub 2019 Apr 9.

PMID:
30972456
24.

A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy.

Yoshimatsu K, Ishibashi K, Koda K, Yokomizo H, Oda N, Oshiro M, Kato H, Oya M, Nakajima H, Ooki S, Maekawa H, Matsunami T, Tsubaki M, Yamada T, Kobayashi M, Tanakaya K, Yokoyama M, Ishida H.

Surg Today. 2019 Jun;49(6):498-506. doi: 10.1007/s00595-019-1771-y. Epub 2019 Apr 5.

PMID:
30953164
25.

Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure.

Fujita K, Matsumoto N, Ishida H, Kubota Y, Iwai S, Shibanuma M, Kato Y.

Curr Drug Metab. 2019;20(5):361-376. doi: 10.2174/1389200220666190402143125.

PMID:
30947665
26.

A health crisis during the Japanese Medieval Period: A new paleodemographic perspective.

Nagaoka T, Ishida H, Tsurumoto T, Wakebe T, Saiki K, Hirata K.

Int J Paleopathol. 2019 Mar 30. pii: S1879-9817(17)30163-8. doi: 10.1016/j.ijpp.2019.03.005. [Epub ahead of print]

PMID:
30940508
27.

Association between immune-related adverse events and prognosis in patients with metastatic renal cell carcinoma treated with nivolumab.

Ishihara H, Takagi T, Kondo T, Homma C, Tachibana H, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Okumi M, Ishida H, Tanabe K.

Urol Oncol. 2019 Jun;37(6):355.e21-355.e29. doi: 10.1016/j.urolonc.2019.03.003. Epub 2019 Mar 29.

PMID:
30935847
28.

Prognostic Markers for Refined Stratification of IMDC Intermediate-Risk Metastatic Clear Cell Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitor Therapy.

Takagi T, Fukuda H, Kondo T, Ishihara H, Yoshida K, Kobayashi H, Iizuka J, Okumi M, Ishida H, Tanabe K.

Target Oncol. 2019 Apr;14(2):179-186. doi: 10.1007/s11523-019-00634-8.

PMID:
30927174
29.

Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy.

Yoshida K, Takagi T, Kondo T, Kobayashi H, Iizuka J, Fukuda H, Ishihara H, Okumi M, Ishida H, Tanabe K.

Jpn J Clin Oncol. 2019 Jun 1;49(6):576-580. doi: 10.1093/jjco/hyz040.

PMID:
30924496
30.

Chyloretroperitoneum secondary to retroperitoneoscopic live donor nephrectomy: A single-center experience.

Yang J, Ishida H, Men T.

Asian J Surg. 2019 Jul;42(7):775-776. doi: 10.1016/j.asjsur.2019.03.001. Epub 2019 Mar 23. No abstract available.

31.

Identification of retrograde peristalsis determines the afferent limb during double-balloon ERCP: the tidal wave sign.

Iwasaki T, Akasaka T, Sakakibara Y, Nakazuru S, Ishida H, Mita E.

Endoscopy. 2019 Jun;51(6):E141-E142. doi: 10.1055/a-0866-9226. Epub 2019 Mar 25. No abstract available.

PMID:
30909299
32.

Range-ambiguity artifact in abdominal ultrasound.

Naganuma H, Ishida H, Nagai H, Ogawa M, Ohyama Y.

J Med Ultrason (2001). 2019 Jul;46(3):317-324. doi: 10.1007/s10396-019-00938-2. Epub 2019 Mar 19. Review.

PMID:
30888535
33.

Pure versus hand-assisted retroperitoneoscopic live donor nephrectomy: a retrospective cohort study of 1508 transplants from two centers.

Noguchi H, Kakuta Y, Okumi M, Omoto K, Okabe Y, Ishida H, Nakamura M, Tanabe K.

Surg Endosc. 2019 Mar 19. doi: 10.1007/s00464-019-06697-y. [Epub ahead of print]

PMID:
30888499
34.

The single-base-pair deletion, MSH2 c.2635-3delC affecting intron 15 splicing can be a cause of Lynch syndrome.

Ito T, Yamaguchi T, Wakatsuki T, Suzuki T, Eguchi H, Okazaki Y, Yamamoto G, Tachikawa T, Kawakami S, Sasaki A, Akagi K, Ishida H.

Jpn J Clin Oncol. 2019 May 1;49(5):477-480. doi: 10.1093/jjco/hyz031.

PMID:
30882153
35.

Correlation between the magnitude of best tumor response and patient survival in nivolumab therapy for metastatic renal cell carcinoma.

Ishihara H, Takagi T, Kondo T, Tachibana H, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Okumi M, Ishida H, Tanabe K.

Med Oncol. 2019 Mar 16;36(4):35. doi: 10.1007/s12032-019-1261-5.

PMID:
30879157
36.

High rates of ovarian function preservation after hematopoietic cell transplantation with melphalan-based reduced intensity conditioning for pediatric acute leukemia: an analysis from the Japan Association of Childhood Leukemia Study (JACLS).

Fujino H, Ishida H, Iguchi A, Onuma M, Kato K, Shimizu M, Yasui M, Fujisaki H, Hamamoto K, Washio K, Sakaguchi H, Miyashita E, Osugi Y, Nakagami-Yamaguchi E, Hayakawa A, Sato A, Takahashi Y, Horibe K.

Int J Hematol. 2019 May;109(5):578-583. doi: 10.1007/s12185-019-02627-9. Epub 2019 Mar 12.

PMID:
30864117
37.

Validation of a novel digital health monitoring system to measure the volume of voided urine.

Miyazato M, Yonemoto K, Ashikari A, Saito S, Yamashiro K, Uehara M, Masuzaki H, Ishida H, Matsushita M.

Neurourol Urodyn. 2019 Apr;38(4):1106-1110. doi: 10.1002/nau.23965. Epub 2019 Mar 8.

PMID:
30848839
38.

[Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].

Tamefusa K, Fukutake K, Ishida H, Tamura A, Endo M, Hamamoto K, Koga Y, Yamada M, Kanamitsu K, Fujiwara K, Washio K, Shimada A.

Rinsho Ketsueki. 2019;60(2):99-105. doi: 10.11406/rinketsu.60.99. Japanese.

PMID:
30842387
39.

Remission of Congenital Multi-system Type Langerhans Cell Histiocytosis with Chemotherapy.

Tamefusa K, Ishida H, Washio K, Ishida T, Morita H, Shimada A.

Acta Med Okayama. 2019 Feb;73(1):61-65. doi: 10.18926/AMO/56459.

40.

A comparative analysis of clinicopathological factors between esophageal small cell and basaloid squamous cell carcinoma.

Ishida H, Kasajima A, Onodera Y, Konno T, Maruyama S, Okamoto H, Sato C, Heishi T, Sakurai T, Taniyama Y, Takahashi M, Fujishima F, Jingu K, Ishioka C, Sasano H, Kamei T.

Medicine (Baltimore). 2019 Feb;98(8):e14363. doi: 10.1097/MD.0000000000014363.

41.

Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38.

Iwase M, Fujita KI, Nishimura Y, Seba N, Masuo Y, Ishida H, Kato Y, Kiuchi Y.

Cancer Chemother Pharmacol. 2019 May;83(5):993-998. doi: 10.1007/s00280-019-03784-8. Epub 2019 Feb 13.

PMID:
30810774
42.

Selective laser trabeculoplasty for steroid glaucoma in a child with leukemia.

Ishida H, Araki R, Iwase T, Naito T, Shimada A.

Pediatr Int. 2019 Feb;61(2):208-210. doi: 10.1111/ped.13754. Epub 2019 Feb 7. No abstract available.

PMID:
30809881
43.

Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial).

Usui K, Yokoyama T, Naka G, Ishida H, Kishi K, Uemura K, Ohashi Y, Kunitoh H.

Jpn J Clin Oncol. 2019 Jun 1;49(6):554-558. doi: 10.1093/jjco/hyz023.

44.

Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study.

Ishida H, Shimizu Y, Sakaguchi H, Nitanda H, Kaneko K, Yamazaki N, Yanagihara A, Taguchi R, Sakai F, Yasuda M, Kobayashi K.

Lung Cancer. 2019 Mar;129:16-21. doi: 10.1016/j.lungcan.2018.12.020. Epub 2018 Dec 19.

45.

[Surgical Outcome of Sublobar Resection in High-risk Patients with Non-small Cell Lung Cancer].

Nitanda H, Taguchi R, Yanagihara A, Sakaguchi H, Ishida H, Kaneko K.

Kyobu Geka. 2019 Jan;72(1):17-22. Japanese.

PMID:
30765624
46.

Poly(benzoxazine-f-chitosan) films: The role of aldehyde neighboring groups on chemical interaction of benzoxazine precursors with chitosan.

Alhwaige AA, Ishida H, Qutubuddin S.

Carbohydr Polym. 2019 Apr 1;209:122-129. doi: 10.1016/j.carbpol.2019.01.016. Epub 2019 Jan 6.

PMID:
30732791
47.

Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia.

Okamoto Y, Kudo K, Tabuchi K, Tomizawa D, Taga T, Goto H, Yabe H, Nakazawa Y, Koh K, Ikegame K, Yoshida N, Uchida N, Watanabe K, Koga Y, Inoue M, Kato K, Atsuta Y, Ishida H.

Bone Marrow Transplant. 2019 Feb 4. doi: 10.1038/s41409-019-0461-0. [Epub ahead of print]

PMID:
30718800
48.

Treatment of oral cancers during pregnancy: a case-based discussion.

Sato K, Shimamoto H, Mochizuki Y, Hirai H, Tomioka H, Shimizu R, Marukawa E, Fukayama H, Yoshimura R, Ishida H, Harada H.

J Otolaryngol Head Neck Surg. 2019 Feb 4;48(1):9. doi: 10.1186/s40463-019-0331-1.

49.

Alleviation of mechanical stress-induced allodynia by improving blood flow in chronic constriction injury mice.

Ishida H, Saito SY, Horie A, Ishikawa T.

Eur J Pharmacol. 2019 Apr 15;849:67-74. doi: 10.1016/j.ejphar.2019.02.002. Epub 2019 Feb 2.

PMID:
30716308
50.

Serum lactate levels are associated with serum alanine aminotransferase and total bilirubin levels in patients with type 2 diabetes mellitus: A cross-sectional study.

Ishitobi M, Hosaka T, Morita N, Kondo K, Murashima T, Kitahara A, Takahashi K, Sumitani Y, Tanaka T, Yokoyama T, Kondo T, Ishida H.

Diabetes Res Clin Pract. 2019 Mar;149:1-8. doi: 10.1016/j.diabres.2019.01.028. Epub 2019 Jan 31.

Supplemental Content

Loading ...
Support Center